Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-02-18

Clinical Trial Update: Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients

View source ↗

Summary

A completed clinical trial evaluating whether a combined pharmacogenetic score influences trough voriconazole concentrations in patients with invasive aspergill…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VORICONAZOLE (Voriconazole)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Invasive Aspergillosis, Haematological Cancer Patients | Status: COMPLETED